Report Contents
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & working
1.3 Forecast calculation
1.4 Data sources
1.4.1 Primary
1.4.2 Data mining sources
1.4.2.1 Paid sources
1.4.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360-degree synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.1.1 Key manufacturers
3.1.2 Distributors
3.1.3 Profit margins across the industry
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rapidly growing wound dressing/healing market
3.2.1.2 Growing R&D in biomedical industry in U.S. for novel drug delivery
3.2.1.3 Rising product demand for tissue engineering in biomedical industry
3.2.2 Market challenges
3.2.2.1 Volatile raw material prices
3.2.3 Market opportunity
3.2.3.1 New opportunities
3.2.3.2 Growth potential analysis
3.3 Raw material landscape
3.3.1 Manufacturing trends
3.3.2 Technology evolution
3.4 Sustainable manufacturing
3.4.1.1 Green practices
3.4.1.2 Decarbonization
3.4.2 Sustainability in raw materials
3.5 Pricing trends (USD/Ton), 2021 to 2032
3.5.1 North America
3.5.2 Europe
3.5.3 Asia Pacific
3.5.4 Latin America
3.5.5 Middle East & Africa
3.6 Regulations & market impact
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.3.1 Company Market share analysis by region
4.3.1.1 North America
4.3.1.2 Europe
4.3.1.3 Asia Pacific
4.3.1.4 Latin America
4.3.1.5 Middle East Africa
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Cross-linking, 2021 – 2032 (Kilo Tons) (USD Million)
5.1 Key trends
5.2 Physical
5.3 Chemical
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 (Kilo Tons) (USD Million)
6.1 Key trends
6.2 Wound healing
6.3 Drug delivery
6.4 Tissue engineering
6.5 Surface coating
6.6 3D printing
6.7 Soft robots
6.8 Others
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 (Kilo Tons) (USD Million)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Russia
7.4 Asia Pacific
7.4.1 China
7.4.2 India
7.4.3 Japan
7.4.4 South Korea
7.4.5 Australia
7.4.6 Indonesia
7.4.7 Malaysia
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.6 Middle East and Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 South Africa
Chapter 8 Company Profiles
8.1 Advanced Medical Solutions Group PLC
8.2 Alliqua Biomedical
8.3 Axelgaard
8.4 Cardinal Health
8.5 Contura International S.A.
8.6 Cytogel Pharma
8.7 Ferentis
8.8 Hydromer, Inc.
8.9 Katecho, Inc.
8.10 Scapa Healthcares
